FLS Earnings Arrive With Bears on the Back Foot
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Flowserve heads into its Q3 2026 results today with short sellers trimming positions and the lending market showing no signs of stress, yet analysts have quietly been marking down their targets ahead of the print.
Short interest at 6.7% of the free float is meaningful but has been easing. Positions fell roughly 1.2% over the past week to 8.5 million shares, and have retreated further from the spike that briefly pushed borrowing demand sharply higher in late September. The lending market is relaxed: availability stands at 548%, meaning roughly five and a half shares sit available for every one currently lent out, well above the 152% trough hit on September 25. Cost to borrow is 0.57%, low by any measure, and barely changed over the past month. There is no squeeze pressure building here. Options positioning is marginally more defensive than usual, with the put/call ratio at 0.11 compared to a 20-day average of 0.105, about 1.7 standard deviations above that mean, but the absolute level remains extremely low by the stock's own 52-week range of 0.09 to 1.39. Options traders are not pricing in a dramatic move. The stock closed at $71.81, up 1.4% on Tuesday but still about 3% lower than a month ago.
The debate heading into the print is essentially about margins versus growth. The bull case rests on a strong operational story: adjusted margins expanded 370 basis points year-on-year to 14.8% last quarter, and demand from North American and Middle Eastern customers alongside a resurgence in nuclear and traditional power bookings gives the top line a credible growth runway. Bears point to the guidance cut that accompanied that strong margin report. Organic sales growth was trimmed to 1% to 3%, well below prior expectations, and the stock has drifted lower since that revision. Analysts broadly kept their constructive ratings intact but trimmed targets in the weeks before today: Mizuho cut to $85 from $91 earlier this month, RBC followed with a move to $88 from $94, both maintaining Outperform. The consensus mean target is $87.60 against a current price of $71.81, implying about 22% upside on the Street's base case, though that gap reflects the stock's pullback rather than any fresh enthusiasm.
The ownership picture adds one noteworthy detail. BlackRock has been building its position and now holds 10.6% of shares, the largest single institutional stake. D1 Capital trimmed by around 906,000 shares to 3.9% as of June 30, the most notable reduction among major holders. The past two earnings prints have been well-received: the July 2026 release produced a one-day gain of 8.7% and extended to 12.4% over five days, while the print reported the same evening in late July delivered a further 2.6% and 7.1% respectively. The stock has consistently rewarded earnings days.
Today's report tests whether the margin expansion story remains intact at the same time as organic growth re-accelerates toward the upper end of that 1% to 3% guidance range, and whether management's commentary on power and aftermarket bookings can give the Street enough confidence to push targets back toward their prior highs.
Stocks in this article
See the live data behind this article on ORTEX.
Open FLS on ORTEX →How this article was generated
- Generated
- 29 Oct 2026, 04:27
- Data as of
- 29 Oct 2026, 04:06
- Prompt version
- v1.0
- Data sources
- Short interestCost to borrowUtilizationOptions flowEarningsAnalyst consensusInstitutional positioningORTEX Alpha signalsRecent ORTEX notesAlt Data
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.